TrianglePUBLICATIONS · 14999298
Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Leukemia
- Publication date
- 2004 May
- First author
- Holowiecki J
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Holowiecki J
- type
- Author
- name
- Grosicki S
- type
- Author
- name
- Robak T
- type
- Author
- name
- Kyrcz-Krzemien S
- type
- Author
- name
- Giebel S
- type
- Author
- name
- Hellmann A
- type
- Author
- name
- Skotnicki A
- type
- Author
- name
- Jedrzejczak WW
- type
- Author
- name
- Konopka L
- type
- Author
- name
- Kuliczkowski K
- type
- Author
- name
- Zdziarska B
- type
- Author
- name
- Dmoszynska A
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Holowiecki J
- type
- Author
- name
- Grosicki S
- type
- Author
- name
- Robak T
- type
- Author
- name
- Kyrcz-Krzemien S
- type
- Author
- name
- Giebel S
- type
- Author
- name
- Hellmann A
- type
- Author
- name
- Skotnicki A
- type
- Author
- name
- Jedrzejczak WW
- type
- Author
- name
- Konopka L
- type
- Author
- name
- Kuliczkowski K
- type
- Author
- name
- Zdziarska B
- type
- Author
- name
- Dmoszynska A
- type
- Author
- bibliography ids
- nci-bib-9ab1211f749f49471eda578f
- book metadata
- content sha256
- a9f7f8761c91131e8b22974cdfd06079c3b08483af976cc1ff90deacbbeb706c
- document type
- citation
- dois
- 10.1038/sj.leu.2403336
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:14999298
- immutable id
- pubmed:14999298@a9f7f8761c91131e8b22974cdfd06079c3b08483af976cc1ff90deacbbeb706c
- journal
- abbreviation
- Leukemia
- issn electronic
- Source null
- issn print
- 0887-6924
- issue
- 5
- name
- Leukemia
- nlm unique id
- 8704895
- pages
- 989-97
- volume
- 18
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 14999298
- provenance
- batch id
- aee154f17d1b0501fe1f
- provider
- NCBI PubMed ESummary
- record sha256
- ec26057a3df2aae4626d2ecb7b7aa0ccf6d4dd13f895bbc5230bc9f676cbbe6f
- response sha256
- 75a826407a9022d376294c7400982e19a458458cea55b2628fd3fddd75bc0f08
- retrieved at
- 2026-09-09T23:45:53.270896+00:00
- publication date
- display
- 2004 May
- precision
- month
- year
- 2004
- publication types
- Clinical Trial
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study.
Preserved source evidence · Not medical advice